Key result
Irbesartan slows diabetic nephropathy progression independently of its blood pressure-lowering effect.
Why the study?
Does irbesartan prevent the progression of nephropathy in patients with nephropathy due to type 2 diabetes?
Does irbesartan prevent the progression of nephropathy in patients with nephropathy due to type 2 diabetes?
Irbesartan provides renoprotection against the progression of diabetic nephropathy independent of its blood pressure-lowering effects.
Answers are grounded in this paper and cite their sources.
Supports irbesartan for renoprotection in type 2 diabetic nephropathy beyond BP lowering; confirms independent ARB benefit in this population.
The angiotensin-II-receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the reduction in blood pressure it causes.
No takes yet. Share an insight, caveat, or question.
Lewis et al. (2001) studied this question. Irbesartan effectively protects against the progression of nephropathy due to type 2 diabetes, independent of its blood pressure-lowering effect.
Synapse has enriched 10 related papers. Consider them for comparative context: